Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
University Health Network, Toronto
University Health Network, Toronto
University of Nebraska
Canadian Cancer Trials Group
University of Maryland, Baltimore
Montefiore Medical Center
Weill Medical College of Cornell University
Alliance for Clinical Trials in Oncology
AIDS Malignancy Consortium
SWOG Cancer Research Network
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Scripps Health
Temple University
National Cancer Institute (NCI)
Keio University
Eli Lilly and Company